one
import
aspect
mucos
immun
system
clinic
medicin
role
develop
obstruct
airway
diseas
although
mucos
immun
system
undoubtedli
crucial
surviv
human
certain
ill
probabl
result
inabl
regul
select
compon
immun
respons
occur
mucos
site
particularli
airway
contrast
recurr
bacteri
pneumonia
repeat
infect
sinus
middl
ear
caviti
occur
individu
immunolog
deficit
express
mucos
site
wheez
airway
hyperreact
induc
viral
infect
occur
individu
unabl
regul
certain
immun
pathway
otherwis
immunolog
intact
result
disregul
viral
bronchiol
infanc
asthma
later
life
associ
common
today
wellrecogn
histopatholog
featur
includ
exuber
inflamm
lower
airway
mucosa
although
mani
inflammatori
cell
appear
involv
inflammatori
respons
quit
uniqu
airway
mucosa
infiltr
lymphocyt
helper
type
phenotyp
eosinophil
composit
cellular
respons
depend
upon
discret
targetcel
select
chemotact
molecul
cytokin
chemokin
colonystimul
factor
csf
gener
releas
structur
cell
airway
epitheli
cell
regul
migrat
activ
leukocyt
therefor
play
crucial
role
inflammatori
process
lung
chapter
illustr
clinic
import
virusinduc
wheez
airway
hyperreact
refer
herein
infecti
asthma
review
evid
support
role
immun
system
provok
ill
summar
experiment
data
induc
express
epitheli
cell
cytokin
respiratori
virus
wheez
induc
infecti
agent
occur
frequenc
case
per
children
first
year
life
case
per
children
second
year
case
per
children
third
year
denni
clyde
sever
form
ill
observ
infant
month
age
brandt
et
al
ill
common
sever
male
age
year
incid
becom
similar
sex
denni
clyde
respiratori
syncyti
viru
rsv
parainfluenza
virus
influenza
virus
probabl
import
caus
infecti
asthma
infanc
wherea
rhinovirus
predomin
caus
milder
outpati
wheez
older
children
tabl
similar
studi
complet
adult
studi
asthmat
adult
cold
associ
exacerb
asthma
nicholson
et
al
laboratoryconfirm
case
viral
chlamydi
infect
episod
occur
peak
expiratori
flow
fell
mlmin
greater
rhinovirus
presum
import
etiolog
agent
adult
studi
mention
earlier
infect
document
cultur
serolog
mean
neither
techniqu
effici
identif
viral
infect
actual
import
viral
infect
may
underestim
one
studi
use
polymeras
chain
reaction
amplif
nucleic
acid
identifi
infect
agent
children
acut
episod
obstruct
airway
diseas
virus
chlamydia
could
detect
episod
children
experienc
reduct
peak
expiratori
flow
rate
impress
amount
inform
gather
concern
role
immun
system
rsv
influenza
rhinoviru
infect
regard
mechan
erad
primari
infect
pathogenesi
sever
diseas
prevent
reinfect
review
immun
respons
infect
specif
agent
provid
overal
perspect
probabl
appli
infect
viral
agent
clinic
present
rsv
major
caus
seriou
lower
respiratori
diseas
infanc
earli
childhood
estim
episod
lower
respiratori
diseas
caus
rsv
occur
everi
children
follow
first
month
life
reinfect
second
year
life
extrem
common
occur
substanti
frequenc
age
glezen
et
al
therefor
although
individu
develop
rel
mild
symptom
time
rsv
infect
certain
individu
seem
prone
develop
lower
respiratori
ill
particular
bronchiol
time
rsv
infectionth
fact
bronchiol
well
croup
seen
wide
varieti
viral
agent
suggest
develop
ill
entir
specif
featur
rsv
similar
featur
varieti
virus
well
uniqu
host
compon
inocul
rsv
occur
nasal
mucos
surfac
eye
hall
et
al
incub
period
assum
least
day
time
infect
child
develop
symptom
rhinorrhea
nasal
obstruct
lowgrad
fever
patient
ill
resolv
day
other
cough
becom
progress
eventu
sign
lower
respiratori
tract
involv
appear
point
secret
profus
contain
infecti
unit
viru
per
millilit
secret
hall
et
al
case
pneumonia
descent
viru
lower
respiratori
tract
probabl
occur
result
aspir
syndrom
bronchiol
whether
diseas
entir
result
spread
viru
bronchiol
occur
stimul
patholog
immun
respons
simultan
yet
clear
case
child
point
manifest
respiratori
distress
may
sever
nasal
flare
dyspnea
retract
note
auscult
chest
reveal
rhonchi
harsh
wheez
otherwis
child
remain
remark
free
symptom
fever
usual
mark
child
may
quit
activ
despit
presenc
moder
hypoxia
suggest
sever
ill
may
mediat
least
part
mechan
progress
viral
infect
histolog
pictur
rsv
pneumonia
reveal
mononuclear
cell
within
alveolar
wall
small
airway
engorg
capillari
bed
edema
also
note
lymphocyt
plasma
cell
recruit
alveolar
wall
alveolar
wall
may
becom
increasingli
thick
fill
proteinac
materi
intranuclear
cytoplasm
inclus
giant
cell
may
observ
ahern
et
al
bronchiol
contrast
character
necrosi
slough
respiratori
epithelium
plug
small
bronchiol
fibrin
mucu
intens
peribronchiolar
infiltr
lymphocyt
plasma
cell
occur
consider
edema
local
hyperinfl
due
airflow
obstruct
characterist
atelectasi
common
precis
role
rsvspecif
antibodi
recoveri
primari
infect
controversi
local
antibodi
respons
predominantli
secretori
iga
class
appear
respiratori
tract
shortli
onset
primari
infect
mcintosh
et
al
kaul
et
al
studi
mcintosh
et
al
viral
shed
termin
time
appear
antibodi
secret
howev
studi
kaul
et
al
antibodi
present
time
substanti
quantiti
viru
still
recover
respiratori
tract
thu
role
specif
secretori
iga
antibodi
termin
infect
uncertain
although
repeat
infect
tend
result
acceler
local
antibodi
respons
kaul
et
al
reduc
sever
ill
whether
local
antibodi
respons
protect
clear
one
studi
adult
undergo
experiment
rsv
challeng
specif
nasal
iga
antibodi
titer
correl
protect
infect
hall
et
al
investig
mill
et
al
neutral
activ
nasal
secret
appar
correl
partial
resist
infect
howev
subsequ
studi
mcintosh
et
al
demonstr
neutral
activ
necessarili
antibodi
summari
rsvspecif
secretori
iga
antibodi
present
time
infect
prevent
reinfect
may
reduc
degre
viral
replic
serumneutr
antibodi
may
effect
provid
immun
studi
adult
experiment
challeng
rsv
preexist
titer
neutral
antibodi
serum
secret
provid
degre
protect
infect
hyperimmun
human
antiserum
rsv
prepar
plasmapheresi
donor
select
basi
highserum
rsvneutral
antibodi
titer
infus
monthli
basi
infant
high
risk
seriou
rsv
infect
compound
reduc
rate
rsvrelat
hospit
prevent
studi
group
therefor
serum
antibodi
presum
appear
respiratori
tract
transud
follow
infect
rsv
appear
better
associ
protect
detect
infect
local
synthes
iga
antibodi
nevertheless
even
highest
titer
antibodi
serum
respiratori
secret
seem
provid
absolut
protect
rsv
mani
adult
infect
despit
high
antibodi
titer
mill
et
al
hall
et
al
cellmedi
immun
mechan
may
also
import
recoveri
rsv
infect
individu
congenti
acquir
defect
cellmedi
immun
function
shed
viru
prolong
period
seem
greater
frequenc
develop
pneumonia
immunolog
intact
individu
fishaut
et
al
hall
et
al
lymphocyt
express
cytotox
activ
rsvinfect
cell
demonstr
peripher
blood
human
infant
appear
time
viral
shed
begin
decreas
issac
et
al
chiba
et
al
mbawuik
et
al
cytotox
cell
cytotox
activ
appear
mhc
restrict
express
cell
infect
rsv
virus
cytotox
activ
cell
correl
directli
ifng
express
invers
express
role
cell
protect
pathogenesi
remain
uncertain
studi
lymphocyt
obtain
respiratori
tract
complet
potenti
mechan
certain
virus
may
induc
airway
hyperreact
obstruct
airway
diseas
includ
tabl
rsvspecif
ige
antibodi
respons
document
respiratori
secret
sera
infant
young
children
undergo
natur
rsv
infect
welliv
et
al
bui
et
al
russi
et
al
rabat
et
al
aberl
et
al
secretori
iga
ige
appear
first
bound
surfac
rsvinfect
cell
later
free
secret
welliv
et
al
higher
concentr
rsvige
observ
infant
bronchiol
comparison
infant
upper
respiratori
ill
alon
bui
et
al
rsvspecif
ige
titer
respiratori
secret
also
associ
greater
degre
hypoxia
time
acut
infect
suggest
form
sever
ill
partial
determin
magnitud
rsvige
respons
histamin
detect
respiratori
secret
plasma
infant
rsv
bronchiol
substanti
role
immedi
hypersensit
respons
rsv
infect
leukotrien
particularli
identifi
respiratori
secret
infant
rsv
infect
volovitz
et
al
garofalo
et
al
van
schaik
et
al
although
direct
correl
leukotrien
content
secret
sever
ill
observ
compound
may
nevertheless
contribut
airway
obstruct
occur
rsv
infect
although
autopsi
studi
infant
fatal
rsv
infect
reveal
presenc
eosinophil
airway
nevertheless
eosinophil
cation
protein
compon
eosinophil
granul
toxic
respiratori
epithelium
detect
sever
investig
respiratori
secret
infant
rsv
infect
garofalo
et
al
ingram
et
al
garofalo
et
al
eosinophilia
peripher
blood
suppress
time
rsv
infect
although
suppress
overcom
somewhat
subject
bronchiol
particularli
male
possibl
eosinophil
present
respiratori
mucosa
degranul
time
rsv
infect
replac
time
autopsi
fatal
case
thu
although
eosinophil
certainli
degranul
respiratori
tract
rsv
infect
exact
role
eosinophil
rsv
infect
uncertain
especi
preliminari
observ
suggest
degranul
eosinophil
occur
lower
airway
obstruct
establish
rc
welliv
person
commun
hand
recent
studi
demonstr
eosinophil
expos
rsv
abl
secret
inflammatori
cytokin
olszewskapazdrak
et
al
cultur
presenc
rsvinfect
airway
epitheli
cell
releas
eosinophil
cation
protein
olszewskapazdrak
et
al
evid
also
suggest
exagger
tcell
respons
may
result
enhanc
lung
diseas
follow
rsv
infect
reconstitut
rsvinfect
mice
cytotox
cell
repeatedli
stimul
rsv
antigen
clear
viru
rapidli
lung
result
enhanc
mortal
increas
histopatholog
chang
lung
cannon
et
al
whether
similar
event
occur
human
known
infant
rsv
bronchiol
report
peripher
blood
lymphocyt
respons
rsv
antigen
similar
cell
infant
upper
respiratori
infect
alon
rsv
welliv
et
al
addit
recipi
inactiv
rsv
vaccin
develop
evid
cellmedi
hypersensit
rsv
vaccin
subsequ
develop
enhanc
lung
diseas
natur
infect
rsv
kim
et
al
asthma
certain
evid
suggest
airway
diseas
result
overexpress
thelper
type
cytokin
especi
cytokin
import
synthesi
ige
antibodi
migrat
activ
eosinophil
predomin
airway
inflammatori
cell
asthma
mice
previous
vaccin
formalininactiv
vaccin
enhanc
diseas
human
rsv
infect
caus
increas
express
mrna
wari
et
al
human
polymorph
gene
associ
sever
form
rsvrelat
ill
choi
et
al
hoebe
et
al
howev
stimul
lymphocyt
rsvinfect
human
caus
express
mrna
cytokin
ifng
primarili
littl
express
essenti
increas
anderson
et
al
mbawuik
et
al
tripp
et
al
pattern
reflect
studi
measur
cytokin
protein
secret
rsvinfect
infant
studi
ifng
predomin
wherea
smaller
amount
detect
rare
detect
infant
bronchiol
van
schaik
et
al
garofalo
et
al
although
ifng
predomin
cytokin
present
bronchiol
evid
infant
sever
form
ill
lesser
ifng
respons
milder
form
bronchiol
aberl
et
al
bont
et
al
garofalo
et
al
johnston
et
al
freihorst
et
al
leibovitz
et
al
allergen
riedel
et
al
schwarz
et
al
antivir
immun
respons
antibodymedi
antivir
ige
rsv
parainfluenza
welliv
et
al
welliv
et
al
bui
et
al
russi
et
al
rabat
et
al
aberl
et
al
cellmedi
andor
rsv
rhinoviru
influenza
openshaw
et
al
corn
andor
holgat
neuzil
graham
airway
mucosa
inflamm
releas
mediat
leukotrien
kinin
rsv
rhinoviru
influenza
volovitz
et
al
garofolo
et
al
tabl
although
littl
data
support
role
bronchiol
certain
chemokin
biolog
effect
present
rsvinfect
infant
sheeran
et
al
chemokin
rant
regul
activ
normal
tlymphocyt
express
secret
mip
macrophag
inflammatori
protein
attract
lymphocyt
eosinophil
activ
mast
cell
basophil
kuna
et
al
altern
may
synthes
lymphocyt
schrum
et
al
rsv
infect
induc
express
mrna
chemokin
well
appear
respiratori
tract
garofalo
et
al
tripp
et
al
overexpress
chemokin
may
result
sever
form
bronchiol
garofalo
et
al
influenza
virus
respons
yearli
outbreak
respiratori
ill
among
age
group
highest
mortal
rate
observ
infant
elderli
characterist
flulik
symptom
includ
fever
headach
intens
myalgia
prolong
malais
cough
may
may
promin
find
especi
earli
illnessth
princip
site
involv
influenza
viru
infect
trachea
bronchi
rsv
infect
lower
respiratori
tract
ill
pneumonia
wheez
common
otherwis
healthi
person
nevertheless
croup
bronchiol
may
occur
infanc
pneumonia
may
occur
age
influenza
infect
respiratori
tract
result
swell
desquam
infect
ciliat
cell
airway
edema
infiltr
mononuclear
polymorphonuclear
cell
follow
extens
slough
layer
basal
cell
influenza
pneumonia
character
hemorrhag
alveolar
infiltr
format
hyalin
membran
mark
lymphocyt
infiltr
interstitium
alveolar
wall
kilbourn
contrast
infect
rsv
virus
influenza
infect
accompani
increas
frequenc
bacteri
superinfect
may
result
reduc
mucociliari
clearanc
follow
influenza
viru
infect
camner
et
al
greater
damag
mucosa
result
diminish
resist
bacteri
invas
kilbourn
suppress
activ
phagocyt
cell
casali
et
al
hartshorn
tauber
initi
infect
one
strain
influenza
viru
provid
partial
immun
reinfect
strain
homotyp
reinfect
gener
asymptomat
frank
et
al
sonoguchi
et
al
resist
reinfect
attribut
presenc
antibodi
serum
respiratori
secret
high
titer
antibodi
either
site
capabl
confer
resist
clement
et
al
whether
local
serum
antibodi
effici
provid
protect
reinfect
human
uncertain
antibodi
hemagglutinin
influenza
appear
contribut
immun
prevent
attach
viru
respiratori
epithelium
wherea
antibodi
neuraminidas
antigen
inhibit
cleavag
preform
viru
cell
membran
ogra
et
al
virtual
data
avail
role
serum
secretori
antibodi
recoveri
primari
influenza
viru
infect
minor
chang
hemagglutinin
structur
variat
amino
acid
sequenc
antigen
drift
major
chang
via
genet
reassort
antigen
shift
enabl
viru
infect
previous
expos
individu
role
cellmedi
immun
influenza
viru
infect
extens
investig
mice
lesser
extent
human
transfer
primari
secondari
influenzaimmun
splenic
cell
mice
infect
intranas
influenza
viru
result
signific
clearanc
viru
lung
protect
death
recipi
lymphocyt
repres
cell
popul
primarili
respons
immun
yap
ada
evid
suggest
pathogenesi
influenza
viru
infect
may
reflect
cellmedi
immun
respons
lung
first
influenza
viru
replic
releas
cell
without
caus
cell
death
second
mice
without
function
cell
develop
extens
replic
viru
lung
dissemin
organ
develop
minim
pulmonari
infiltr
follow
influenza
viru
challeng
wyde
et
al
contrast
cytotox
cell
appear
lung
immunocompet
mice
peak
respiratori
symptom
histopatholog
lung
promin
enni
et
al
although
definit
studi
repeat
human
cytotox
tcell
respons
develop
human
influenza
viru
infect
maxim
respons
occur
second
week
infect
greenberg
et
al
cytotox
cell
appar
recogn
influenza
type
strain
influenza
virus
type
noninfluenza
virus
cytotox
cell
appear
hla
restrict
appar
capabl
provid
protect
subsequ
influenza
viru
infect
even
influenzaspecif
serum
antibodi
undetect
serum
secret
cytotox
respons
appar
short
live
individu
expos
given
strain
influenza
viru
induc
cytotox
tcell
activ
test
year
later
mcmichael
et
al
major
cytotox
tcell
respons
appear
mediat
cell
major
histocompat
complex
mhc
restrict
class
fleischer
et
al
yamada
et
al
addit
specif
cytotox
cell
nonspecif
natur
killer
cell
activ
also
increas
influenza
viru
infect
human
howev
increas
natur
killer
activ
observ
human
continu
shed
viru
individu
continu
shed
viru
enni
et
al
suffici
larg
viral
inoculum
may
abl
overcom
natur
killer
cell
resist
therefor
although
data
mucos
cellmedi
immun
respons
lack
cytotox
cell
circul
blood
appear
import
restrict
primari
viral
infect
result
rsv
influenza
probabl
virus
cytotox
cell
may
play
role
protect
reinfect
almost
undoubtedli
respons
much
histopatholog
seen
viral
infect
lung
evid
exagger
tcell
respons
may
respons
unusu
sever
form
infect
due
rsv
influenza
viru
increas
bronchial
reactiv
frequent
complic
influenza
infect
littl
et
al
laitenen
kava
increas
bronchial
reactiv
associ
loss
epithelium
may
due
either
exposur
airway
irrit
receptor
empey
et
al
loss
natur
inhibitor
airway
reactiv
jacobi
et
al
role
influenzaspecif
ige
respons
inflammatori
respons
mediat
releas
extens
evalu
possibl
role
induc
bronchial
hyperreact
presum
princip
morbid
mortal
result
influenza
viru
infect
manifest
airway
obstruct
nevertheless
requir
induct
inflammatori
respons
anim
model
influenza
viru
infect
cook
et
al
influenza
infect
epitheli
cell
monocyt
result
releas
mani
chemokin
describ
previous
rsv
infect
matsukura
et
al
matsukura
et
al
sprenger
et
al
rhinovirus
frequent
identifi
agent
caus
common
cold
attack
rate
gener
popul
rang
infect
per
person
per
year
higher
rate
children
infect
occur
commonli
spring
autumn
document
yearround
fox
et
al
although
infect
trivial
nevertheless
rhinovirus
recogn
frequent
caus
asthma
exacerb
schoolag
children
adult
nicholson
et
al
johnston
et
al
mild
natur
rhinoviru
infect
autopsi
materi
limit
nasal
biopsi
perform
small
number
individu
natur
experiment
rhinoviru
infect
report
describ
minim
damag
epitheli
cell
rhinoviru
cold
winther
et
al
detect
infect
cell
use
nuclear
probe
techniqu
de
arruda
et
al
impli
either
cell
becom
infect
infect
cell
exfoli
quickli
rapidli
replac
nasal
biopsi
also
reveal
minimum
chang
number
inflammatori
cell
tissu
infect
individu
comparison
preinfect
sampl
fraenkel
et
al
contrast
tissu
sampl
neutrophil
abund
nasal
lavag
fluid
obtain
infect
subject
degre
upper
respiratori
symptom
correl
number
invad
neutrophil
releas
kinin
nasal
secret
naclerio
et
al
howev
remain
uncertain
whether
magnitud
neutrophil
kinin
respons
simpli
reflect
degre
inflamm
actual
respons
manifest
ill
mucos
biopsi
individu
rhinoviru
cold
show
modest
infiltr
lymphocyt
eosinophil
fraenkel
et
al
rhinovirusspecif
antibodi
respons
occur
respiratori
tract
serum
follow
rhinoviru
infect
natur
respons
investig
extens
experiment
infect
respons
becom
detect
week
inocul
barclay
et
al
serum
antibodi
respons
greater
prolong
adult
children
suggest
reinfect
occur
gradual
induc
solid
immun
fox
et
al
cellmedi
respons
also
occur
follow
infect
tonsillar
lymphocyt
prolifer
respons
stimul
rhinoviru
antigen
antigenpres
cell
present
wimalasundera
et
al
respond
cell
produc
interferon
gamma
peripher
blood
number
cell
reduc
suggest
migrat
respiratori
tract
respons
infect
levandowski
et
al
upon
restimul
vitro
peripher
blood
cell
releas
magnitud
respons
correl
invers
viru
shed
nasal
mucu
score
cell
also
releas
interferon
gamma
quantiti
cytokin
produc
correl
virolog
clinic
paramet
hsia
et
al
two
studi
amount
ifng
present
either
parri
et
al
rhinoviru
infect
relat
peak
titer
durat
rhinoviru
shed
studi
cytokin
limit
date
howev
peripher
blood
lymphocyt
recov
rhinovirusinfect
subject
stimul
rhinoviru
releas
ifng
infect
parri
et
al
ratio
chang
markedli
cours
experiment
rhinoviru
cold
higher
ratio
associ
reduc
cold
symptom
studi
mechan
rhinovirus
result
lower
respiratori
diseas
still
unclear
rhinoviru
infect
nonallerg
individu
alter
forc
expiratori
flow
increas
airway
reactiv
histamin
fraenkel
et
al
halperin
et
al
lemansk
et
al
calhoun
et
al
calhoun
et
al
even
subject
allerg
rhiniti
mild
asthma
rhinoviru
infect
appar
alter
lung
function
fraenkel
et
al
lemansk
et
al
calhoun
et
al
calhoun
et
al
indic
simpl
infect
viru
insuffici
caus
airway
obstruct
wheez
question
whether
rhinoviru
infect
induc
chang
airway
reactiv
atop
individu
extens
investig
studi
determin
airway
respons
histamin
allergen
increas
atop
subject
lemansk
et
al
grunberg
et
al
grunberg
et
al
gern
et
al
suggest
rhinoviru
infect
might
provok
wheez
individu
atop
would
presum
occur
increas
reactiv
airway
degre
obstruct
follow
allergen
exposur
would
enhanc
acut
rhinoviru
infect
rhinoviru
infect
appar
increas
reactiv
airway
bradykinin
potent
stimulu
sensori
nerv
therefor
increas
airway
reactiv
induc
rhinoviru
infect
probabl
due
increas
exposur
sensori
nerv
grunberg
et
al
even
though
rhinoviru
infect
may
increas
airway
reactiv
atop
individu
conclud
suffici
result
airway
obstruct
inde
subject
allerg
rhiniti
asthma
develop
increas
airway
reactiv
follow
rhinoviru
infect
wheez
manifest
evid
airway
obstruct
symptomat
airway
obstruct
follow
rhinoviru
infect
must
anoth
basi
pertin
data
regard
gener
lemansk
et
al
calhoun
et
al
calhoun
et
al
normal
individu
ragweedinduc
allerg
rhiniti
experiment
infect
rhinoviru
given
placebo
group
challeng
ragwe
antigen
e
instil
antigen
directli
lung
via
endoscop
chang
pulmonari
function
fvc
occur
individu
howev
group
infect
rhinoviru
challeng
allergen
develop
increas
airway
reactiv
importantli
late
phase
asthmat
respons
lar
defin
fall
occur
hour
allergen
challeng
develop
major
individu
infect
rhinoviru
uninfect
group
lemansk
et
al
calhoun
et
al
result
indic
rhinoviru
infect
may
result
directli
airway
obstruct
howev
suggest
atop
individu
like
develop
airway
obstruct
encount
allergen
sensit
acut
rhinoviru
infect
studi
group
attempt
determin
mechan
rhinoviru
infect
enhanc
potenti
allergeninduc
airway
obstruct
result
studi
indic
histamin
releas
airway
blood
increas
follow
allergen
challeng
atop
individu
infect
rhinoviru
calhoun
et
al
calhoun
et
al
degre
histamin
releas
greater
account
allergen
challeng
calhoun
et
al
suggest
rhinoviru
infect
enhanc
capabl
inflammatori
cell
releas
mediat
follow
allergen
exposur
releas
histamin
tryptas
enhanc
subject
appear
primari
effect
rhinoviru
infect
basophil
recruit
lung
rather
mast
cell
resid
lung
rhinoviru
infect
normal
individu
result
abnorm
histamin
releas
airway
blood
rhinoviru
infrequ
recov
lung
lavag
fluid
experi
even
though
readili
recov
nasopharynx
studi
particip
impli
infect
rhinoviru
limit
upper
respiratori
tract
may
still
caus
enhanc
reflex
releas
mediat
airway
obstruct
lower
respiratori
tract
import
observ
regard
attempt
develop
rhinoviru
vaccin
vaccin
effect
prevent
asthma
induc
rhinovirus
may
need
capabl
prevent
rhinoviru
infect
absolut
rather
simpli
restrict
upper
respiratori
tract
summari
avail
data
suggest
rhinoviru
infect
import
caus
lower
respiratori
diseas
primarili
individu
underli
asthma
even
princip
effect
rhinoviru
infect
may
enhanc
respons
allergen
individu
sensit
precis
mechan
appear
involv
increas
degranul
basophil
perhap
eosinophil
support
autopsi
find
child
fatal
rhinoviru
infect
la
hera
swanson
infant
symptom
asthma
month
die
unexpectedli
rhinoviru
type
recov
lung
blood
lung
find
autopsi
consist
acut
asthma
includ
mucu
plug
eosinophil
infiltr
airway
addit
clinic
epidemiolog
relationship
bronchiol
infanc
asthma
later
life
hall
et
al
sigur
et
al
two
diseas
link
common
histopatholog
featur
character
profound
inflamm
airway
mucosa
mention
earlier
chapter
necrosi
bronchial
epithelium
associ
peribronchi
perivascular
mononuclear
cell
infiltr
consid
hallmark
rsv
infect
human
ahern
et
al
anim
model
princ
et
al
graham
et
al
moreov
presenc
cellspecif
inflammatori
mediat
nasopharyng
secret
children
bronchiol
suggest
rsv
infect
trigger
migrat
airway
local
activ
eosinophil
basophil
leukocyt
garofalo
et
al
garofalo
et
al
sigur
et
al
colocho
zelaya
et
al
ingram
et
al
specif
antivir
immun
respons
appear
play
role
pathogenesi
rsvinduc
airway
inflamm
howev
sever
studi
suggest
mechan
may
also
trigger
sustain
lung
inflamm
follow
viral
chapter
clinic
aspect
bronchial
reactiv
cellviru
interact
infect
regard
although
defens
foreign
organ
virus
bacteria
mediat
innat
specif
acquir
immun
effector
phase
natur
specif
immun
larg
mediat
cytokin
molecul
oper
network
produc
cascad
effect
contribut
orchestr
develop
function
immun
system
cytokin
tumor
necrosi
factor
tnf
mediat
regul
inflammatori
respons
often
associ
immun
respons
review
arai
et
al
exampl
induc
cytokin
gene
protein
synthesi
secret
wide
varieti
cell
type
increas
express
adhes
molecul
endotheli
cell
modul
cell
surfac
molecul
critic
cellcel
interact
leukocyt
migrat
review
dinarello
addit
pivot
role
inflammatori
cytokin
much
cellular
respons
site
tissu
inflamm
control
gradient
chemotact
factor
direct
leukocyt
transendotheli
migrat
movement
extracellular
matrix
composit
cellular
respons
depend
discret
targetcel
select
chemotact
molecul
chemokin
newli
identifi
famili
small
chemotact
cytokin
regul
migrat
activ
leukocyt
therefor
play
key
role
inflammatori
process
lung
review
oppenheim
et
al
two
subfamili
cxc
cc
chemokin
defin
splice
conserv
cystein
residu
either
separ
one
amino
acid
cxc
chemokin
adjac
cc
chemokin
growthrel
peptid
gro
belong
cxc
famili
mainli
chemotact
factor
neutrophil
howev
member
cc
branch
chemokin
famili
rant
regul
upon
activ
normal
cell
express
presum
secret
macrophag
inflammatori
monocyt
chemotact
protein
mcp
eotaxin
chemotact
factor
monocyt
basophil
eosinophil
virtual
activ
neutrophil
regard
human
lymphocyt
rant
shown
specif
chemotact
cell
memori
phenotyp
review
baggiolini
et
al
chemokin
receptor
bind
eotaxin
rant
found
express
cell
cell
sallusto
et
al
express
cell
also
function
eotaxin
rantesinduc
intracellular
ca
increas
chemotaxi
clone
colonystimul
factor
csf
growth
factor
control
prolifer
stem
cell
differenti
along
granulocyt
pathway
csf
defin
type
granulocyt
coloni
induc
cultur
includ
neutrophil
colonystimul
factor
gcsf
macrophag
colonystimul
factor
mcsf
granulocytemacrophag
colonystimul
factor
gmcsf
gmcsf
recogn
import
factor
stimul
hematopoiesi
prolong
eosinophil
surviv
ruef
coleman
also
enhanc
releas
silberstein
et
al
eosinophil
cytotox
lopez
et
al
high
concentr
produc
local
inflamm
gmcsf
act
true
chemotaxin
eosinophil
directli
mediat
eosinophil
migrat
warringa
et
al
respiratori
epithelium
repres
princip
cellular
barrier
environ
intern
milieu
airway
epitheli
damag
loss
integr
recogn
featur
asthma
jefferi
et
al
thought
associ
increas
bronchial
hyperrespons
characterist
diseas
boushey
et
al
addit
last
year
becom
clear
epithelium
contact
exogen
stimuli
microbi
infect
activ
modul
local
inflammatori
immun
respons
releas
varieti
mediat
cytokin
regard
human
airway
epitheli
cell
appear
domin
sourc
cc
chemokin
includ
rant
stellato
et
al
standiford
et
al
stellato
et
al
eotaxin
lilli
et
al
among
csf
gmcsf
ohtoshi
et
al
cromwel
et
al
respiratori
epitheli
cell
primari
target
virus
enter
airway
rsv
infect
result
inhal
selfinocul
viru
nasal
mucosa
follow
infect
local
respiratori
epithelium
spread
along
respiratori
tract
occur
mainli
celltocel
transfer
viru
along
intracytoplasm
bridg
hall
et
al
led
current
view
recruit
function
activ
eosinophil
basophil
mononuclear
cell
airway
mucosa
play
key
role
protect
immun
well
develop
virusassoci
wheez
natur
acquir
rsv
infect
activ
research
past
year
led
discoveri
number
cytokin
chemokin
csf
produc
vitro
virusinfect
respiratori
epitheli
cell
cell
line
primari
cultur
tabl
first
cytokin
demonstr
supernat
influenzaand
rsvinfect
nasal
bronchial
lung
type
ii
epitheli
cell
synthesi
appear
dose
time
depend
requir
replic
viru
primarili
transcript
induc
arnold
et
al
garofalo
et
al
concurr
discoveri
number
differ
laboratori
report
presenc
supernat
airway
epitheli
cell
infect
rsv
rhinoviru
influenza
viru
tabl
mechan
product
rsvinfect
lung
epitheli
cell
appear
regul
autocrin
releas
less
extent
jiang
et
al
cytokin
potent
bioactiv
infect
epitheli
cell
supernat
regard
shown
enhanc
express
intercellular
adhes
infect
pulmonari
epitheli
cell
patel
et
al
moreov
demonstr
rsv
infect
elicit
product
number
respiratori
epitheli
cell
turn
lead
increas
synthesi
class
mhc
molecul
garofalo
et
al
mice
infect
rsv
develop
lymphocytosi
bronchoalveolar
lavag
bal
fluid
predominantli
cell
openshaw
adopt
transfer
ctl
caus
hemorrhag
pneumon
cannon
et
al
increas
express
class
mhc
respiratori
epitheli
cell
rsv
infect
mark
infect
cell
possibl
neighbor
cell
passiv
acquir
releas
rsv
peptid
ctlmediat
lysi
associ
immunopatholog
thu
increas
class
mhc
mediat
inflammatori
cytokin
releas
infect
airway
mucosa
may
consid
import
compon
immunopatholog
respons
rsv
howev
may
play
equal
import
role
protect
immun
respons
rsv
inhibit
restrict
viral
infect
merolla
et
al
enhanc
express
class
mhc
infect
cell
lysi
rsvspecif
ctl
cytokin
shown
produc
type
ii
lung
cell
infect
rsv
parainfluenza
type
rhinoviru
quit
impress
list
differ
pharmaceut
chemic
agent
shown
modul
vitro
virusinduc
cytokin
product
includ
dexamethason
ribavirin
sodium
salicyl
aspirin
dimethyl
sulfoxid
amilorid
jiang
et
al
bitko
et
al
mastronard
et
al
mastronard
et
al
although
effect
compound
virusinduc
cytokin
may
due
wellknown
antivir
gener
antiinflammatori
properti
exact
mechan
activ
compound
use
studi
poorli
understood
investig
express
releas
cc
chemokin
rant
respons
rsv
primari
cultur
human
noseand
adenoidderiv
epitheli
cell
epitheli
cell
deriv
larg
bronchi
nhbe
termin
bronchiol
sae
cell
use
rtpcr
northern
blot
specif
elisa
profil
concentr
cc
chemokin
produc
respiratori
epithelium
inflammatori
cytokin
rsv
patel
et
al
rsv
rhinoviru
influenza
noah
becker
arnold
et
al
jiang
et
al
subaust
et
al
zhu
et
al
matsukura
et
al
rsv
rhinoviru
parainfluenza
einarsson
et
al
bitko
et
al
rsv
garofalo
et
al
cxc
chemokin
rsv
garofolo
ogra
rsv
rhinoviru
influenza
noah
becker
becker
et
al
arnold
et
al
mastronard
et
al
fielder
et
al
garofolo
et
al
garofolo
et
al
subaust
choi
jacobi
matsukura
et
al
cc
chemokin
rsv
garofalo
ogra
olszewskapazdrak
et
al
rsv
garofalo
ogra
olszewskapazdrak
et
al
rant
rsv
influenza
ogra
saito
et
al
becker
et
al
olszewskapazdrak
et
al
matsukura
et
al
colonystimul
factor
gcsf
rsv
garofolo
ogra
gmcsf
rsv
rhinoviru
noah
et
al
garofalo
ogra
subaust
et
al
characterist
cell
specif
rsv
infect
induc
releas
rant
epitheli
cell
isol
upper
respiratori
airway
saito
et
al
segment
lower
respiratori
tract
olszewskapazdrak
et
al
similar
find
use
bronchial
cell
line
report
anoth
group
becker
et
al
regard
protein
concentr
rsvinfect
epitheli
cell
obtain
distal
portion
bronchial
tree
sae
type
ii
cell
produc
significantli
greater
level
rant
major
bronchi
upper
airway
contrast
widespread
express
rant
infect
respiratori
epithelium
rsv
induc
releas
cell
furthermor
result
demonstr
first
time
infect
human
epitheli
cell
cell
line
normal
sae
cell
abl
express
secret
fig
thu
releas
airway
epitheli
cell
appear
region
distal
segment
bronchial
tree
lung
site
rsvmediat
necrosi
epithelium
peribronchi
cellular
infiltr
associ
greater
patholog
chang
particularli
infect
young
infant
moreov
recent
discov
cc
chemokin
eotaxin
appear
potent
specif
chemoattract
eosinophil
cell
investig
northern
blot
express
eotaxin
mrna
rsvinfect
cell
shown
figur
rsv
infect
cell
induc
accumul
eotaxin
mrna
maxim
accumul
hour
postinfect
rp
garofalo
person
commun
regard
cytokin
known
activ
eosinophil
interest
rsv
rhinoviru
appear
strong
induc
gmcsf
bronchial
lung
epitheli
cell
noah
becker
garofalo
ogra
subaust
et
al
find
import
implic
activ
enhanc
surviv
human
eosinophil
airway
mucosa
still
limit
human
studi
appear
literatur
address
presenc
concentr
clinic
correl
cytokin
biolog
sampl
subject
respiratori
viral
infect
increas
level
measur
nasal
secret
volunt
experiment
rhinoviru
cold
proud
et
al
detect
respiratori
secret
middl
ear
effus
natur
acquir
rsv
infect
matsuda
et
al
noah
et
al
okamoto
et
al
experiment
infect
rhinoviru
demonstr
nasal
lavag
fluid
children
upper
viral
infect
noah
et
al
middl
ear
effus
children
antigenproven
viral
otiti
media
chonmaitre
et
al
mrna
also
found
middl
ear
effus
posit
rsv
genom
okamoto
et
al
addit
detect
vivo
viral
upper
respiratori
infect
total
cellular
rna
extract
fraction
electrophoresi
agaroseformaldehyd
gel
transfer
nitrocellulos
membran
membran
hybrid
plabel
human
eotaxin
cdna
probe
gener
polymeras
chain
reaction
pcr
overnight
appear
high
nasal
wash
children
rsv
lower
respiratori
tract
diseas
decreas
convalesc
neuzil
graham
high
amount
cc
chemokin
rant
demonstr
nasopharyng
secret
infant
differ
form
rsv
respiratori
diseas
becker
et
al
rp
garofalo
rc
welliv
person
commun
induc
gene
encod
cytokin
chemokin
csf
regul
transcript
factor
activ
diversifi
extracellular
stimuli
bind
promot
region
gene
increas
rate
transcript
although
mani
transcript
factor
identifi
involv
regul
gene
two
nuclear
factor
nf
appear
particular
import
identif
factor
control
switch
epitheli
cell
central
understand
virushost
interact
human
basic
domainleucin
zippercontain
transcript
factor
import
transcript
factor
particip
induc
gene
express
acut
infecti
inflammatori
respons
akira
et
al
brasier
kumar
origin
identifi
transcript
factor
bound
induc
enhanc
gene
shown
regul
promot
activ
gene
includ
gmcsf
dunn
et
al
stein
baldwin
acutephas
reactant
angiotensinogen
serum
amyloid
akira
et
al
express
control
tissuetypedepend
fashion
mani
tissu
express
mrna
liver
brain
protein
also
produc
lung
howev
discrep
note
descomb
et
al
although
normal
lung
tissu
fact
one
product
sourc
mrna
protein
almost
undetect
observ
suggest
tissuespecif
factor
involv
control
posttranscript
express
howev
data
brasier
group
indic
human
alveolar
type
ii
epitheli
cell
synthes
transcript
factor
respons
rsv
replic
jamaluddin
et
al
rsv
infect
stimul
translat
synthesi
singl
isoform
comigr
recombin
amino
acid
induct
independ
chang
mrna
associ
increas
rate
synthesi
thu
accumul
rsv
infect
due
increas
translat
preform
mrna
mechan
enhanc
translat
preform
mrna
use
rsv
contrast
effect
influenza
viru
infect
hela
cell
wada
et
al
influenza
viru
infect
increas
rapidli
transient
hour
dnabind
activ
preform
protein
without
chang
steadyst
level
effect
could
reproduc
doublestrand
rna
left
suggest
doublestrand
rna
kinas
could
import
virusinduc
activ
posttransl
activ
dnabind
activ
thu
activ
appear
induc
sever
distinct
posttransl
mechan
viral
infect
within
epitheli
cell
type
induc
transcript
activ
implic
induc
express
viral
cytokin
acutephas
reactant
gene
bind
regulatori
site
within
promot
gene
review
baeuerl
thano
maniati
relev
pulmonari
inflamm
activ
express
mani
inflammatori
gene
product
gmcsf
whose
express
known
enhanc
rsv
infect
see
tabl
patel
et
al
therefor
activ
may
respons
activ
gene
network
inflammatori
molecul
cell
surfac
receptor
requir
immun
activ
bronchial
mucosa
shown
previous
tabl
vitro
studi
shown
dramat
product
airway
epitheli
cell
rsv
infect
incomplet
character
mechan
involv
enhanc
gene
express
thu
use
model
lung
type
ii
alveolar
epitheli
cell
studi
initi
event
viralinduc
regul
gene
express
investig
mechan
induct
rsv
infect
infect
sucros
purifi
rsv
produc
timedepend
increas
transcript
initi
rate
gene
transient
transfect
human
promot
mutat
bind
site
demonstr
sequenc
essenti
rsvactiv
transcript
garofalo
et
al
gel
mobil
shift
assay
emsa
demonstr
rsv
induct
sequencespecif
bind
complex
transcript
factor
superfamili
compos
rel
crel
protein
heterodimer
cell
express
produc
complex
variou
transcript
activ
subtl
sequencespecif
bind
prefer
reason
also
test
whether
induc
complex
crossreact
specif
antibodi
variou
subunit
emsa
complex
supershift
antibodi
direct
potent
transactiv
subunit
rel
western
immunoblot
indirect
immunofluoresc
assay
show
cytoplasm
rel
uninfect
cell
local
nucleu
rsv
infect
rel
activ
requir
replic
rsv
neither
viral
condit
medium
uvinactiv
rsv
abl
stimul
transloc
laboratori
demonstr
increas
dnabind
activ
follow
rsv
infect
bitko
et
al
fielder
et
al
mastronard
et
al
simultan
increas
nuclear
abund
potent
transcript
activ
bitko
et
al
event
appear
essenti
also
activ
genet
network
includ
cytokin
rsvinfect
epithelium
bitko
et
al
moreov
activ
report
consequ
sendai
viru
infect
fibroblast
renal
carcinoma
cell
garoufali
et
al
rhinoviru
infect
alveolar
epitheli
cell
kinet
rel
activ
respons
rsv
infect
occur
slowli
requir
hour
significantli
detect
protein
accumul
nucleu
garofalo
et
al
contrast
extrem
rapid
activ
respons
hormon
receptor
activ
within
minut
intermedi
activ
observ
rhinoviru
infect
investig
use
nonpurifi
viral
prepar
shown
biphas
effect
activ
fielder
et
al
mastronard
et
al
initi
transient
replicationindepend
increas
bind
seen
minut
postinfect
follow
nadir
gradual
reaccumul
hour
differ
kinet
well
pattern
cytokin
inflammatori
gene
express
may
due
contamin
nonpurifi
viral
prepar
activ
cytokin
activ
known
produc
human
epitheli
cell
routin
use
rsv
respiratori
viru
growth
observ
impli
although
activ
may
final
common
pathway
infecti
inflammatori
signal
event
mediat
distinct
intracellular
signal
mechan
rsv
infect
note
kinet
rel
activ
coincid
product
viral
antigen
time
cours
observ
product
occur
respons
exposur
rsvcondit
medium
uvinactiv
viru
argu
process
activ
viral
replic
may
necessari
trigger
bind
subsequ
synthesi
inde
viral
product
replic
free
radic
schreck
et
al
doublestrand
rna
visvanathan
goodbourn
potent
activ
certain
cell
type
interest
specul
express
one
viral
gene
product
may
respons
activ
rel
transloc
fig
induc
subunit
interact
cytoplasm
inhibitor
collect
known
motif
contain
within
conserv
rel
homolog
domain
subunit
respons
cytoplasm
retent
inactiv
dnabind
activ
consist
predominantli
four
isoform
precursor
express
regul
cellspecif
fashion
beg
baldwin
signal
control
cytoplasmicnuclear
abund
mechan
involv
proteolyt
degrad
inhibitor
liber
free
cytoplasm
pass
nuclear
pore
complex
enter
nucleu
bind
activ
target
gene
stimul
cell
result
rapid
serin
phosphoryl
terminu
event
coupl
rapid
polyubiquitin
proteolysi
proteasom
didonato
et
al
airway
epitheli
cell
p
fig
infect
alveolar
type
ii
epitheli
cell
rsv
result
rapid
synthesi
within
hour
basic
domainleucin
zippercontain
transcript
factor
addit
rsv
infect
result
activ
ie
rel
dna
bind
begin
hour
peak
hour
involv
proteolysi
inhibitor
via
still
unknown
larg
proteasomeindepend
pathway
cytoplasmicnuclear
transloc
reia
bind
reia
regulatori
consensu
site
within
promot
cytokin
adhes
molecul
inflammatori
gene
respons
transcript
role
specif
rsv
protein
translat
regul
activ
current
unknown
vrna
viral
rna
n
p
g
f
l
identifi
rsv
protein
systemat
investig
mechan
kinet
activ
rsvinfect
airway
epitheli
cell
comparison
tnfa
jamaluddin
et
al
contrast
rapid
activ
rel
produc
rsv
infect
produc
gradual
increas
rel
bind
peak
hour
activ
rsv
proteolysi
occur
parallel
increas
rel
dnabind
activ
specif
proteasom
inhibitor
lactacystin
zllfcho
significantli
block
proteas
activ
proteolysi
induc
howev
although
total
proteasom
activ
rsvinfect
cell
increas
twofold
activ
almost
complet
inhibit
proteasom
inhibitor
prevent
proteolysi
rsv
infect
data
indic
major
compon
proteolysi
occur
via
proteasomeindepend
mechan
viralinfect
epithelium
rsv
common
etiolog
agent
worldwid
induc
lower
respiratori
tract
infect
infant
young
children
link
develop
asthma
airway
hyperrespons
sensit
environment
allergen
mechan
rsvinduc
airway
diseas
longterm
consequ
larg
unknown
delic
balanc
immunopatholog
immunoprotect
airway
mucosa
may
alter
exuber
unwant
local
inflammatori
respons
massiv
infiltr
mononuclear
cell
activ
eosinophil
basophil
leukocyt
shown
correl
sever
acut
rsv
diseas
human
anim
model
inflammatori
cytokin
cc
chemokin
discret
targetcel
select
eosinophil
cell
strongli
induc
express
rsvinfect
respiratori
epithelium
propos
cohes
hypothesi
link
rsv
perhap
respiratori
viral
infect
develop
respiratori
allerg
diseas
induc
product
cc
chemokin
rsv
regul
intracellular
pathway
signal
mechan
character
increas
rate
synthesi
cytoplasmicnuclear
transloc
potent
transcript
factor
lead
transcript
induct
cc
chemokin
gene
secret
cc
chemokin
includ
rant
eotaxin
respiratori
epitheli
cell
combin
cytokin
central
pathogenet
event
airway
mucosa
inflamm
sensit
bystand
antigen
augment
allergeninduc
cell
recruit
moreov
pattern
absolut
level
well
rel
concentr
togeth
kinet
releas
epitheli
cell
chemokin
differ
area
respiratori
tract
factor
may
significantli
contribut
variou
histolog
inflammatori
featur
rsvinduc
airway
diseas
select
product
severalfold
higher
amount
rant
releas
epitheli
cell
small
bronchiol
lung
comparison
bronchial
upper
airway
epithelium
along
autocrin
paracrin
mechan
amplif
may
larg
explain
find
mononuclear
cell
infiltr
eosinophil
basophil
migrat
activ
futur
studi
children
differ
form
rsvinduc
airway
diseas
anim
model
need
correl
differ
paramet
histopatholog
inflamm
immun
respons
express
secret
cytokin
chemokin
csf
airway
mucosa
